Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
297 hedge funds and large institutions have $3.41B invested in Amedisys in 2018 Q4 according to their latest regulatory filings, with 64 funds opening new positions, 121 increasing their positions, 86 reducing their positions, and 31 closing their positions.
106% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 31
41% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 86
14% more call options, than puts
Call options by funds: $14.8M | Put options by funds: $13M
12% more funds holding
Funds holding: 265 → 297 (+32)
2.68% less ownership
Funds ownership: 94.85% → 92.17% (-2.7%)
10% less capital invested
Capital invested by funds: $3.77B → $3.41B (-$361M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$57.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$47.4M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$31M |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$26.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$22.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
-$272M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$52.7M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$33.3M |
| 4 |
O
OppenheimerFunds
New York
|
-$18.9M |
| 5 |
EOJOAM
E. Ohman J:or Asset Management
Stockholm,
Sweden
|
-$15.1M |
AMED Hedge Fund Activity: Q4 2018 in Review
297 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2018, worth a combined $3.41B — down 9.6% from $3.77B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new AMED positions and 31 closed out — a net gain of 33 holders — while 121 added to existing stakes and 86 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $57.3M. The largest seller was Kohlberg Kravis Roberts & Co, cutting an estimated $272M.
- 297 institutional investors held Amedisys (AMED) as of Q4 2018, up from 265 in Q3 2018.
- Funds reported $3.41B of Amedisys stock for Q4 2018, down 9.6% quarter-over-quarter.
- 64 funds opened new Amedisys positions in Q4 2018 and 31 closed out, a net change of +33 holders.
- The largest Amedisys buyer in Q4 2018 was AllianceBernstein, an estimated $57.3M added.
- The largest Amedisys seller in Q4 2018 was Kohlberg Kravis Roberts & Co, an estimated $272M sold.
Based on aggregated 13F filings for Q4 2018.